These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

8023 related items for PubMed ID: 1759558

  • 41. Pattern of brain destruction in Parkinson's and Alzheimer's diseases.
    Braak H, Braak E, Yilmazer D, de Vos RA, Jansen EN, Bohl J.
    J Neural Transm (Vienna); 1996; 103(4):455-90. PubMed ID: 9617789
    [Abstract] [Full Text] [Related]

  • 42. The extent of neurofibrillary pathology in perforant pathway neurons is the key determinant of dementia in the very old.
    García-Sierra F, Hauw JJ, Duyckaerts C, Wischik CM, Luna-Muñoz J, Mena R.
    Acta Neuropathol; 2000 Jul; 100(1):29-35. PubMed ID: 10912917
    [Abstract] [Full Text] [Related]

  • 43. Striation is the characteristic neuritic abnormality in Alzheimer disease.
    Velasco ME, Smith MA, Siedlak SL, Nunomura A, Perry G.
    Brain Res; 1998 Dec 07; 813(2):329-33. PubMed ID: 9838181
    [Abstract] [Full Text] [Related]

  • 44. The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease.
    Delacourte A, David JP, Sergeant N, Buée L, Wattez A, Vermersch P, Ghozali F, Fallet-Bianco C, Pasquier F, Lebert F, Petit H, Di Menza C.
    Neurology; 1999 Apr 12; 52(6):1158-65. PubMed ID: 10214737
    [Abstract] [Full Text] [Related]

  • 45. Apolipoprotein E immunoreactivity in neurons and neurofibrillary degeneration of aged non-demented and Alzheimer's disease patients.
    Gómez-Ramos P, Mufson EJ, Morán MA.
    Microsc Res Tech; 2001 Oct 01; 55(1):48-58. PubMed ID: 11596149
    [Abstract] [Full Text] [Related]

  • 46. The presubicular region in Alzheimer's disease: topography of amyloid deposits and neurofibrillary changes.
    Kalus P, Braak H, Braak E, Bohl J.
    Brain Res; 1989 Aug 07; 494(1):198-203. PubMed ID: 2765920
    [Abstract] [Full Text] [Related]

  • 47. Alzheimer's disease: mismatch between amyloid plaques and neuritic plaques.
    Braak H, Braak E, Ohm T, Bohl J.
    Neurosci Lett; 1989 Aug 14; 103(1):24-8. PubMed ID: 2476692
    [Abstract] [Full Text] [Related]

  • 48. Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.
    Monsell SE, Kukull WA, Roher AE, Maarouf CL, Serrano G, Beach TG, Caselli RJ, Montine TJ, Reiman EM.
    JAMA Neurol; 2015 Oct 14; 72(10):1124-31. PubMed ID: 26302353
    [Abstract] [Full Text] [Related]

  • 49. Neurofibrillary tangles in nondemented elderly subjects and mild Alzheimer disease.
    Haroutunian V, Purohit DP, Perl DP, Marin D, Khan K, Lantz M, Davis KL, Mohs RC.
    Arch Neurol; 1999 Jun 14; 56(6):713-8. PubMed ID: 10369312
    [Abstract] [Full Text] [Related]

  • 50. [Expression of proteins related neurodegeneration in autopsy brains of the aged].
    Zhu M, Meng X, Wang L, Hu Y, Zhang H, Han Z.
    Zhonghua Bing Li Xue Za Zhi; 2014 Oct 14; 43(10):651-6. PubMed ID: 25567589
    [Abstract] [Full Text] [Related]

  • 51. The importance of neuritic plaques and tangles to the development and evolution of AD.
    Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J.
    Neurology; 2004 Jun 08; 62(11):1984-9. PubMed ID: 15184601
    [Abstract] [Full Text] [Related]

  • 52. Plasma membrane fragility in dystrophic neurites in senile plaques of Alzheimer's disease: an index of oxidative stress.
    Praprotnik D, Smith MA, Richey PL, Vinters HV, Perry G.
    Acta Neuropathol; 1996 Jun 08; 91(1):1-5. PubMed ID: 8773139
    [Abstract] [Full Text] [Related]

  • 53. Stage-correlated distribution of type 1 and 2 dystrophic neurites in cortical and hippocampal plaques in Alzheimer's disease.
    Thal DR, Härtig W, Schober R.
    J Hirnforsch; 1998 Jun 08; 39(2):175-81. PubMed ID: 10022341
    [Abstract] [Full Text] [Related]

  • 54. Brainstem tau pathology in Alzheimer's disease is characterized by increase of three repeat tau and independent of amyloid β.
    Uematsu M, Nakamura A, Ebashi M, Hirokawa K, Takahashi R, Uchihara T.
    Acta Neuropathol Commun; 2018 Jan 03; 6(1):1. PubMed ID: 29298724
    [Abstract] [Full Text] [Related]

  • 55. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
    Güntert A, Döbeli H, Bohrmann B.
    Neuroscience; 2006 Dec 01; 143(2):461-75. PubMed ID: 17008022
    [Abstract] [Full Text] [Related]

  • 56. Evolution of neuronal changes in the course of Alzheimer's disease.
    Braak H, Braak E.
    J Neural Transm Suppl; 1998 Dec 01; 53():127-40. PubMed ID: 9700651
    [Abstract] [Full Text] [Related]

  • 57. Cortical and subcortical argyrophilic grains characterize a disease associated with adult onset dementia.
    Braak H, Braak E.
    Neuropathol Appl Neurobiol; 1989 Dec 01; 15(1):13-26. PubMed ID: 2471109
    [Abstract] [Full Text] [Related]

  • 58. Tau pathology in diffuse neurofibrillary tangles with calcification (DNTC): biochemical and immunohistochemical investigation.
    Tanabe Y, Ishizu H, Ishiguro K, Itoh N, Terada S, Haraguchi T, Kawai K, Kuroda S.
    Neuroreport; 2000 Aug 03; 11(11):2473-7. PubMed ID: 10943706
    [Abstract] [Full Text] [Related]

  • 59. Dystrophic neurites are associated with early stage extracellular neurofibrillary tangles in the parkinsonism-dementia complex of Guam.
    Schwab C, Steele JC, McGeer PL.
    Acta Neuropathol; 1997 Nov 03; 94(5):486-92. PubMed ID: 9386782
    [Abstract] [Full Text] [Related]

  • 60. Application of the National Institute on Aging (NIA)-Reagan Institute criteria for the neuropathological diagnosis of Alzheimer disease.
    Newell KL, Hyman BT, Growdon JH, Hedley-Whyte ET.
    J Neuropathol Exp Neurol; 1999 Nov 03; 58(11):1147-55. PubMed ID: 10560657
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 402.